ArticleLeukemia2016

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.

R Thijssen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.